What is the recommended management for a 28-year-old male with acute near-total sensorineural hearing loss and tinnitus in the right ear of 7‑hour duration?

Immediate Management of Acute Sudden Sensorineural Hearing Loss

This patient requires urgent audiometry within 24-48 hours to confirm sudden sensorineural hearing loss (SSNHL), followed by immediate initiation of high-dose oral corticosteroids (prednisone 60 mg daily or equivalent) within the current 7-hour window—treatment should not be delayed beyond 2 weeks from symptom onset for optimal outcomes. 1, 2

Immediate Actions (Within 24-48 Hours)

1. Confirm the Diagnosis with Audiometry

• Obtain formal audiometry as soon as possible (ideally within 24-48 hours, but must be within 14 days of symptom onset) 1
• SSNHL is defined as ≥30 dB hearing loss across 3 consecutive frequencies occurring within 72 hours
• Do NOT wait for audiometry to initiate treatment if clinical suspicion is high—the 7-hour presentation window is critical

2. Rule Out Conductive Hearing Loss

• Perform otoscopic examination to exclude cerumen impaction, middle ear effusion, or tympanic membrane perforation 2
• Tuning fork tests (Weber and Rinne) can distinguish sensorineural from conductive loss at bedside
• This patient's "near-total" unilateral loss with tinnitus strongly suggests sensorineural pathology

3. Initiate Corticosteroid Therapy Immediately

Recommended regimen 2:

• Prednisone 60 mg daily (or 1 mg/kg/day, max 60 mg) for 7-14 days, then taper over similar duration
• Alternative: Methylprednisolone 48 mg daily or Dexamethasone 10 mg daily
• Do not delay treatment—efficacy decreases significantly after 2 weeks from onset 1
• At 7 hours post-onset, this patient is in the optimal treatment window

Key consideration: If the patient has contraindications to systemic steroids (uncontrolled diabetes, active peptic ulcer, severe hypertension, psychiatric history with steroids), intratympanic steroid injections are equally effective as initial therapy 2

What NOT to Do

• Do NOT order routine CT head imaging unless focal neurologic findings are present 1, 2
• Do NOT order routine laboratory tests (CBC, metabolic panel, autoimmune panels)—these do not change management 1
• Do NOT prescribe antivirals, vasodilators, thrombolytics, or vasoactive substances—strong evidence against routine use 1, 2

Follow-Up Imaging and Evaluation (Within 2-6 Weeks)

Screen for Retrocochlear Pathology

• MRI with gadolinium of internal auditory canals and brain is recommended to exclude vestibular schwannoma (acoustic neuroma) 1, 2
• Alternative: Auditory brainstem response (ABR) testing if MRI contraindicated, though less sensitive
• This can be scheduled after initial treatment is started—does not need to be emergent unless neurologic symptoms present

Salvage Therapy Options (If Incomplete Recovery at 2-6 Weeks)

If hearing does not fully recover after initial corticosteroid course 1, 2:

1. Intratympanic steroid injections (recommended salvage therapy)

   • Dexamethasone 24 mg/mL or methylprednisolone 40 mg/mL
   • 0.4-0.8 mL injected into middle ear space
   • Up to 4 injections over 2-week period
   • Patient keeps head tilted (affected ear up) for 15-30 minutes post-injection

2. Hyperbaric oxygen therapy (HBOT) combined with steroids (optional)

   • May be offered within 2 weeks as initial therapy or within 1 month as salvage 1, 2
   • Requires specialized facility access

Patient Education and Prognosis

Natural history 2:

• Approximately 33-66% of patients experience spontaneous recovery within 2 weeks without treatment
• Patients who recover 50% of hearing in first 2 weeks have better prognosis
• Maximum improvement typically occurs within 2 weeks, though some recovery can continue up to 4 months 3

Adverse prognostic factors 4:

• Hearing loss >90 dB
• Presence of vertigo at onset
• Delayed treatment (>2 weeks)
• Flat or downsloping audiogram
• Advanced age

Common steroid side effects to counsel about 2:

• Insomnia, increased appetite, weight gain, mood changes, hyperglycemia, hypertension, gastric irritation
• Monitor blood glucose in diabetics and blood pressure in hypertensives
• Most serious side effects occur with chronic use—short 10-14 day course is generally well-tolerated

Long-Term Follow-Up

• Repeat audiometry at completion of treatment and again within 6 months 1, 2
• Counsel about audiologic rehabilitation if residual hearing loss persists—discuss hearing aids, assistive devices, and coping strategies 1
• Address persistent tinnitus with sound therapy, counseling, or referral to audiologist 5

Critical Pitfalls to Avoid

1. Delaying treatment while waiting for audiometry—start steroids based on clinical suspicion if audiometry cannot be obtained immediately
2. Assuming bilateral hearing loss or recurrent episodes are "typical" SSNHL—these require different workup for systemic causes 2
3. Ordering unnecessary tests (labs, CT head) that delay treatment initiation
4. Failing to arrange MRI follow-up—vestibular schwannomas must be excluded even if hearing recovers